Chemotherapy agent cisplatin induces 48-h Fos expression in the brain of a vomiting species, the house musk shrew (Suncus murinus) (American Journal of Physiology Regulatory Integrative and Comparative Physiology (2009) 296, (R902-R911) DOI 10.1152/ajpregu.90952.2008));Chemotherapy agent cisplatin induces 48-h Fos expression in the brain of a vomiting species, the house musk shrew (Suncus murinus)

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 296, Issue 4, 2009, Pages

  De Jonghe, Bart C ^a   Horn, Charles C ^a  

^a MONELL CHEMICAL SENSES CENTER   (United States)

Author keywords

Emesis; Palonosetron; Serotonin type 3 receptor

Indexed keywords

CISPLATIN; PALONOSETRON; PROTEIN FOS; SODIUM CHLORIDE;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA POSTREMA; ARTICLE; BRAIN; CONTROLLED STUDY; DORSAL MOTOR NUCLEUS; FEMALE; FOREBRAIN; MESENCEPHALON; NONHUMAN; PARABRACHIAL NUCLEUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHOMBENCEPHALON; SHREW; SOLITARY TRACT NUCLEUS; SUNCUS MURINUS; VOMITING;

EID: 65949104491     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.zh6-6808-corr.2008     Document Type: Erratum

References (74)

1. Aapro MS. How do we manage patients with refractory or breakthrough emesis? Support Care Cancer 10: 106-109, 2002.
2. Aapro MS, Grunberg SM, Manikhas GM, Olivares G, Suarez T, Tjulandin SA, Bertoli LF, Yunus F, Morrica B, Lordick F, Macciocchi A. A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy. Ann Oncol 17: 1441-1449, 2006. (Pubitemid 44400384)
3. Akmaev IG, Kalimullina LB, Sharipova LA. The central nucleus of the amygdaloid body of the brain: cytoarchitectonics, neuronal organization, connections. Neurosci Behav Physiol 34: 603-610, 2004.
4. Andrews PL, Davis CJ, Bingham S, Davidson HI, Hawthorn J, Maskell L. The abdominal visceral innervation and the emetic reflex: pathways, pharmacology, and plasticity. Can J Physiol Pharmacol 68: 325-345, 1990. (Pubitemid 20107636)
5. Andrews PL, Horn CC. Signals for nausea and emesis: implications for models of upper gastrointestinal diseases. Auton Neurosci 125: 100-115, 2006.
6. Andrews PL, Okada F, Woods AJ, Hagiwara H, Kakaimoto S, Toyoda M, Matsuki N. The emetic and anti-emetic effects of the capsaicin analogue resiniferatoxin in Suncus murinus, the house musk shrew. Br J Pharmacol 130: 1247-1254, 2000. (Pubitemid 30488586)
7. Ariumi H, Saito R, Nago S, Hyakusoku M, Takano Y, Kamiya H. The role of tachykinin NK-1 receptors in the area postrema of ferrets in emesis. Neurosci Lett 286: 123-126, 2000. (Pubitemid 30312905)
8. Beleslin DB, Krstic SK. Further studies on nicotine-induced emesis: nicotinic mediation in area postrema. Physiol Behav 39: 681-686, 1987.
9. Bojkowska K, Hamczyk MM, Tsai HW, Riggan A, Rissman EF. Neuropeptide Y influences acute food intake and energy status affects NPY immunoreactivity in the female musk shrew (Suncus murinus). Horm Behav 53: 342-350, 2008.
10. Cabezos PA, Vera G, Castillo M, Fernandez-Pujol R, Martin MI, Abalo R. Radiological study of gastrointestinal motor activity after acute cisplatin in the rat. Temporal relationship with pica. Auton Neurosci 141: 54-65, 2008.
11. Carpenter DO, Briggs DB, Strominger N. Responses of neurons of canine area postrema to neurotransmitters and peptides. Cell Mol Neurobiol 3: 113-126, 1983. (Pubitemid 14087274)
12. Cepeda V, Fuertes MA, Castilla J, Alonso C, Quevedo C, Perez JM. Biochemical mechanisms of cisplatin cytotoxicity. Anticancer Agents Med Chem 7: 3-18, 2007. (Pubitemid 46062402)
13. Constenla M. 5-HT3 receptor antagonists for prevention of late acute-onset emesis. Ann Pharmacother 38: 1683-1691, 2004. (Pubitemid 39297769)
14. De Jonghe BC, Horn CC. Chemotherapy-induced pica and anorexia are reduced by common hepatic branch vagotomy in the rat. Am J Physiol Regul Integr Comp Physiol 294: R756-R765, 2008.
15. Eglen RM, Lee CH, Smith WL, Johnson LG, Clark R, Whiting RL, Hegde SS. Pharmacological characterization of RS 25259-197, a novel and selective 5-HT3 receptor antagonist, in vivo. Br J Pharmacol 114: 860-866, 1995.
16. Eisenberg P, Figueroa-Vadillo J, Zamora R, Charu V, Hajdenberg J, Cartmell A, Macciocchi A, Grunberg S. Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist: results of a phase III, single-dose trial versus dolasetron. Cancer 98: 2473-2482, 2003. (Pubitemid 37466663)
17. Eisenberg P, MacKintosh FR, Ritch P, Cornett PA, Macciocchi A. Efficacy, safety and pharmacokinetics of palonosetron in patients receiving highly emetogenic cisplatin-based chemotherapy: a dose-ranging clinical study. Ann Oncol 15: 330-337, 2004. (Pubitemid 38262636)
18. Endo T, Minami M, Nakayasu M, Hirafuji M, Hamaue N, Omae N, Kang Y, Iwanaga T. Effects of granisetron and vagotomy on c-fos mRNA expression in the rat medulla oblongata as assessed by in situ hybridization. Biomed Res (Tokyo) 25: 229-235, 2004. (Pubitemid 41520008)
19. Fukuda H, Koga T, Furukawa N, Nakamura E, Hatano M, Yanagihara M. The site of the antiemetic action of NK1 receptor antagonists. In: Antiemetic Therapy, edited by Donnerer J. Basel: Karger, 2003, p. 33-77.
20. Fukui H, Yamamoto M. Methotrexate produces delayed emesis in dogs: a potential model of delayed emesis induced by chemotherapy. Eur J Pharmacol 372: 261-267, 1999. (Pubitemid 29255967)
21. Gralla R, Lichinitser M, Van Der Vegt S, Sleeboom H, Mezger J, Peschel C, Tonini G, Labianca R, Macciocchi A, Aapro M. Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron. Ann Oncol 14: 1570-1577, 2003. (Pubitemid 37304615)
22. Hainsworth JD, Hesketh PJ. Single-dose ondansetron for the prevention of cisplatin-induced emesis: efficacy results. Semin Oncol 19: 14-19, 1992.
23. Higa GM, Auber ML, Altaha R, Piktel D, Kurian S, Hobbs G, Landreth K. 5-Hydroxyindoleacetic acid and substance P profiles in patients receiving emetogenic chemotherapy. J Oncol Pharm Pract 12: 201-209, 2006. (Pubitemid 46091933)
24. Horn CC. Is there a need to identify new anti-emetic drugs? Drug Discov Today Ther Strateg 4: 183-187, 2007.
25. Horn CC. Why is the neurobiology of nausea and vomiting so important? Appetite 50: 430-434, 2008.
26. Horn CC, Ciucci M, Chaudhury A. Brain Fos expression during 48 h after cisplatin treatment: neural pathways for acute and delayed visceral sickness. Auton Neurosci 132: 44-51, 2007. (Pubitemid 46274539)
27. Horn CC, Richardson EJ, Andrews PL, Friedman MI. Differential effects on gastrointestinal and hepatic vagal afferent fibers in the rat by the anti-cancer agent cisplatin. Auton Neurosci 115: 74-81, 2004.
28. Ito H, Nishibayashi M, Kawabata K, Maeda S, Seki M, Ebukuro S. Immunohistochemical demonstration of c-fos protein in neurons of the medulla oblongata of the musk shrew (Suncus murinus) after veratrine administration. Exp Anim 51: 19-25, 2002. (Pubitemid 135695652)
29. Ito H, Nishibayashi M, Kawabata K, Maeda S, Seki M, Ebukuro S. Induction of Fos protein in neurons in the medulla oblongata after motion- and X-irradiation-induced emesis in musk shrews (Suncus murinus). Auton Neurosci 107: 1-8, 2003. (Pubitemid 36961475)
30. Ito H, Nishibayashi M, Maeda S, Seki M, Ebukuro S. Emetic responses and neural activity in young musk shrews during the breast-feeding/weaning period: comparison between the high and low emetic response strains using a shaking stimulus. Exp Anim 54: 301-307, 2005. (Pubitemid 41349843)
31. Ito H, Seki M. Ascending projections from the area postrema and the nucleus of the solitary tract of Suncus murinus: anterograde tracing study using Phaseolus vulgaris leucoagglutinin. Okajimas Folia Anat Jpn 75: 9-31, 1998. (Pubitemid 128525273)
32. Jia HG, Rao ZR, Shi JW. An indirect projection from the nucleus of the solitary tract to the central nucleus of the amygdala via the parabrachial nucleus in the rat: a light and electron microscopic study. Brain Res 663: 181-190, 1994.
33. Kinzig KP, D'Alessio DA, Seeley RJ. The diverse roles of specific GLP-1 receptors in the control food intake and the response to visceral illness. J Neurosci 22: 10470-10476, 2002.
34. Kris MG, Gralla RJ, Clark RA, Tyson LB, Groshen S. Control of chemotherapy-induced diarrhea with the synthetic enkephalin BW942C: a randomized trial with placebo in patients receiving cisplatin. J Clin Oncol 6: 663-668, 1988. (Pubitemid 18106160)
35. Kris MG, Hesketh PJ, Somerfield MR, Feyer P, Clark-Snow R, Koeller JM, Morrow GR, Chinnery LW, Chesney MJ, Gralla RJ, Grunberg SM. American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. J Clin Oncol 24: 2932-2947, 2006. (Pubitemid 46630595)
36. Lagasse LD, Pretorius RG, Petrilli ES, Ford LC, Hoeschele J, Kean C. The metabolism of cis-dichlorodiammineplatinum (II): distribution, clearance, and toxicity. Am J Obstet Gynecol 139: 791-798, 1981.
37. Leslie RA, Reynolds DJ, Andrews PL, Grahame-Smith DG, Davis CJ, Harvey JM. Evidence for presynaptic 5-hydroxytryptamine3 recognition sites on vagal afferent terminals in the brainstem of the ferret. Neuroscience 38: 667-673, 1990.
38. Malik NM, Liu YL, Cole N, Sanger GJ, Andrews PL. Differential effects of dexamethasone, ondansetron and a tachykinin NK1 receptor antagonist (GR205171) on cisplatin-induced changes in behaviour, food intake, pica and gastric function in rats. Eur J Pharmacol 555: 164-173, 2007. (Pubitemid 46048809)
39. Malik NM, Moore GB, Smith G, Liu YL, Sanger GJ, Andrews PL. Behavioural and hypothalamic molecular effects of the anti-cancer agent cisplatin in the rat: a model of chemotherapy-related malaise? Pharmacol Biochem Behav 83: 9-20, 2006.
40. Massa E, Astara G, Madeddu C, Dessi M, Loi C, Lepori S, Mantovani G. Palonosetron plus dexamethasone effectively prevents acute and delayed chemotherapy-induced nausea and vomiting following highly or moderately emetogenic chemotherapy in pre-treated patients who have failed to respond to a previous antiemetic treatment: comparison between elderly and non-elderly patient response. Crit Rev Oncol Hematol (August 23, 2008); doi:10.1016/j. critrevonc.2008.07.002.
41. Matsuki N, Ueno S, Kaji T, Ishihara A, Wang CH, Saito H. Emesis induced by cancer chemotherapeutic agents in the Suncus murinus: a new experimental model. Jpn J Pharmacol 48: 303-306, 1988. (Pubitemid 18249930)
42. Matsumoto S, Kawasaki Y, Mikami M, Nakamoto M, Tokuyasu H, Kometani Y, Chikumi H, Hitsuda Y, Matsumoto Y, Sasaki T. [Relationship between cancer chemotherapeutic drug-induced delayed emesis and plasma levels of substance P in two patients with small cell lung cancer]. Gan To Kagaku Ryoho 26: 535-538, 1999.
43. Milano S, Blower P, Romain D, Grelot L. The piglet as a suitable animal model for studying the delayed phase of cisplatin-induced emesis. J Pharmacol Exp Ther 274: 951-961, 1995.
44. Miller AD, Nonaka S, Jakus J. Brain areas essential or non-essential for emesis. Brain Res 647: 255-264, 1994. (Pubitemid 24176088)
45. Miller AD, Ruggiero DA. Emetic reflex arc revealed by expression of the immediate-early gene c-fos in the cat. J Neurosci 14: 871-888, 1994.
46. Minami M, Endo T, Hirafuji M, Hamaue N, Liu Y, Hiroshige T, Nemoto M, Saito H, Yoshioka M. Pharmacological aspects of anticancer drug-induced emesis with emphasis on serotonin release and vagal nerve activity. Pharmacol Ther 99: 149-165, 2003. (Pubitemid 36897747)
47. Mungarndee SS, Lundy RF Jr, Norgren R. Central gustatory lesions and learned taste aversions: unconditioned stimuli. Physiol Behav 87: 542-551, 2006. (Pubitemid 43356689)
48. Nelson K, Walsh D, Sheehan F. Cancer and chemotherapy-related upper gastrointestinal symptoms: the role of abnormal gastric motor function and its evaluation in cancer patients. Support Care Cancer 10: 455-461, 2002. (Pubitemid 36056269)
49. Norgren R, Smith GP. Central distribution of subdiaphragmatic vagal branches in the rat. J Comp Neurol 273: 207-223, 1988. (Pubitemid 18178187)
50. Olson BR, Hoffman GE, Sved AF, Stricker EM, Verbalis JG. Cholecystokinin induces c-fos expression in hypothalamic oxytocinergic neurons projecting to the dorsal vagal complex. Brain Res 569: 238-248, 1992.
51. Parker LA. The role of nausea in taste avoidance learning in rats and shrews. Auton Neurosci 125: 34-41, 2006.
52. Powley TL, Fox EA, Berthoud HR. Retrograde tracer technique for assessment of selective and total subdiaphragmatic vagotomies. Am J Physiol Regul Integr Comp Physiol 253: R361-R370, 1987.
53. Ranson RN, Butler PJ, Taylor EW. The central localization of the vagus nerve in the ferret (Mustela putorius furo) and the mink (Mustela vison). J Auton Nerv Syst 43: 123-137, 1993.
54. Raybould HE, Glatzle J, Robin C, Meyer JH, Phan T, Wong H, Sternini C. Expression of 5-HT3 receptors by extrinsic duodenal afferents contribute to intestinal inhibition of gastric emptying. Am J Physiol Gastrointest Liver Physiol 284: G367-G372, 2003. (Pubitemid 36227884)
55. Reynolds DJ, Barber NA, Grahame-Smith DG, Leslie RA. Cisplatin-evoked induction of c-fos protein in the brainstem of the ferret: the effect of cervical vagotomy and the anti-emetic 5-HT3 receptor antagonist granisetron (BRL 43694). Brain Res 565: 231-236, 1991.
56. Rogers RC, McCann MJ. Intramedullary connections of the gastric region in the solitary nucleus: a biocytin histochemical tracing study in the rat. J Auton Nerv Syst 42: 119-130, 1993.
57. Rudd JA, Andrews PLR. Mechanisms of acute, delayed, and anticipatory emesis induced by anticancer therapies. In: Management of Nausea and Vomiting in Cancer and Cancer Treatment, edited by Hesketh PJ. Sudbury, MA: Jones & Bartlett, 2005, p. 15-65.
58. Rudd JA, Naylor RJ. Effects of 5-HT3 receptor antagonists on models of acute and delayed emesis induced by cisplatin in the ferret. Neuropharmacology 33: 1607-1608, 1994.
59. Rudd JA, Ngan MP, Wai MK. Inhibition of emesis by tachykinin NK1 receptor antagonists in Suncus murinus (house musk shrew). Eur J Pharmacol 366: 243-252, 1999.
60. Saeki M, Sakai M, Saito R, Kubota H, Ariumi H, Takano Y, Yamatodani A, Kamiya H. Effects of HSP-117, a novel tachykinin NK1-receptor antagonist, on cisplatin-induced pica as a new evaluation of delayed emesis in rats. Jpn J Pharmacol 86: 359-362, 2001. (Pubitemid 32743234)
61. Sagar SM, Sharp FR, Curran T. Expression of c-fos protein in brain: metabolic mapping at the cellular level. Science 240: 1328-1331, 1988. (Pubitemid 18155914)
62. Sam TS, Cheng JT, Johnston KD, Kan KK, Ngan MP, Rudd JA, Wai MK, Yeung JH. Action of 5-HT3 receptor antagonists and dexamethasone to modify cisplatin-induced emesis in Suncus murinus (house musk shrew). Eur J Pharmacol 472: 135-145, 2003.
63. Sam TS, Ngan MP, Riendeau D, Robichaud A, Rudd JA. Action of cyclooxygenase inhibitors and a leukotriene biosynthesis inhibitor on cisplatin-induced acute and delayed emesis in the ferret. J Pharmacol Sci 103: 189-200, 2007. (Pubitemid 46294651)
64. Sanger GJ, Andrews PL. Treatment of nausea and vomiting: gaps in our knowledge. Auton Neurosci 129: 3-16, 2006.
65. Saper C. Central autonomic nervous system. In: The Rat Nervous System, edited by Paxinos G. New York: Elsevier, 2004, p. 761-796.
66. Smith JE, Paton JF, Andrews PL. An arterially perfused decerebrate preparation of Suncus murinus (house musk shrew) for the study of emesis and swallowing. Exp Physiol 87: 563-574, 2002.
67. Smith WL, Callaham EM, Alphin RS. The emetic activity of centrally administered cisplatin in cats and its antagonism by zacopride. J Pharm Pharmacol 40: 142-143, 1988.
68. Takeda N, Hasegawa S, Morita M, Matsunaga T. Pica in rats is analogous to emesis: an animal model in emesis research. Pharmacol Biochem Behav 45: 817-821, 1993. (Pubitemid 23213107)
69. Ueno S, Matsuki N, Saito H. Suncus murinus: a new experimental model in emesis research. Life Sci 41: 513-518, 1987. (Pubitemid 17105232)
70. Van Sickle MD, Oland LD, Mackie K, Davison JS, Sharkey KA. Delta9-tetrahydrocannabinol selectively acts on CB1 receptors in specific regions of dorsal vagal complex to inhibit emesis in ferrets. Am J Physiol Gastrointest Liver Physiol 285: G566-G576, 2003. (Pubitemid 37021816)
71. Vera G, Chiarlone A, Martin MI, Abalo R. Altered feeding behaviour induced by long-term cisplatin in rats. Auton Neurosci 126-127: 81-92, 2006. (Pubitemid 43816923)
72. 1 antagonist aprepitant for the prevention of acute and delayed chemotherapy-induced nausea and vomiting: pooled data from 2 randomised, double-blind, placebo controlled trials. Eur J Cancer 41: 1278-1285, 2005.
73. Watson RE Jr, Wiegand SJ, Clough RW, Hoffman GE. Use of cryoprotectant to maintain long-term peptide immunoreactivity and tissue morphology. Peptides 7: 155-159, 1986.
74. Won MH, Matsuo K, Oh YS, Kitoh J. Brainstem topology of the vagal motoneurons projecting to the esophagus and stomach in the house musk shrew, Suncus murinus. J Auton Nerv Syst 68: 171-181, 1998. (Pubitemid 28218212)